{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:08:12Z","timestamp":1789344492058,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Basic Research Program of China","doi-asserted-by":"publisher","award":["Technology helps Economy 2020"],"award-info":[{"award-number":["Technology helps Economy 2020"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Basic Research Program of China","doi-asserted-by":"publisher","award":["2016YFC0106300"],"award-info":[{"award-number":["2016YFC0106300"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010905","name":"Major Research Plan","doi-asserted-by":"publisher","award":["82174230"],"award-info":[{"award-number":["82174230"]}],"id":[{"id":"10.13039\/501100010905","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Military Med Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Benign prostatic hyperplasia (BPH) is highly prevalent among older men, impacting on their quality of life, sexual function, and genitourinary health, and has become an important global burden of disease. Transurethral plasmakinetic resection of prostate (TUPKP) is one of the foremost surgical procedures for the treatment of BPH. It has become well established in clinical practice with good efficacy and safety. In 2018, we issued the guideline\u00a0\u201c2018 Standard Edition\u201d. However much new direct evidence has now emerged and this may change some of previous recommendations. The time is ripe to develop new evidence-based guidelines, so we formed a working group of clinical experts and methodologists. The steering group members posed 31 questions relevant to the management of TUPKP for BPH covering the following areas: questions relevant to the perioperative period (preoperative, intraoperative, and postoperative) of TUPKP in the treatment of BPH, postoperative complications and the level of surgeons\u2019 surgical skill. We searched the literature for direct evidence on the management of TUPKP for BPH, and assessed its certainty generated recommendations using the grade criteria by the European Association of Urology. Recommendations were either strong or weak, or in the form of an ungraded consensus-based statement. Finally, we issued 36 statements. Among them, 23 carried strong recommendations, and 13 carried weak recommendations for the stated procedure. They covered questions relevant to the aforementioned three areas. The preoperative period for TUPKP in the treatment of BPH included indications and contraindications for TUPKP, precautions for preoperative preparation in patients with renal impairment and urinary tract infection due to urinary retention, and preoperative prophylactic use of antibiotics. Questions relevant to the intraoperative period incorporated surgical operation techniques and prevention and management of bladder explosion. The application to different populations incorporating the efficacy and safety of TUPKP in the treatment of normal volume (&lt;\u200980\u00a0ml) and large-volume (\u2265\u200980\u00a0ml) BPH compared with transurethral urethral resection prostate, transurethral plasmakinetic enucleation of prostate and open prostatectomy; the efficacy and safety of TUPKP in high-risk populations and among people taking anticoagulant (antithrombotic) drugs. Questions relevant to the postoperative period incorporated the time and speed of flushing, the time indwelling catheters are needed, principles of postoperative therapeutic use of antibiotics, follow-up time and follow-up content. Questions related to complications incorporated types of complications and their incidence, postoperative leukocyturia, the treatment measures for the perforation and extravasation of the capsule, transurethral resection syndrome, postoperative bleeding, urinary catheter blockage, bladder spasm, overactive bladder, urinary incontinence, urethral stricture, rectal injury during surgery, postoperative erectile dysfunction and retrograde ejaculation. Final questions were related to surgeons\u2019 skills when performing TUPKP for the treatment of BPH. We hope these recommendations can help support healthcare workers caring for patients having TUPKP for the treatment of BPH.<\/jats:p>","DOI":"10.1186\/s40779-022-00371-6","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T22:25:55Z","timestamp":1648765555000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Clinical practice guideline for transurethral plasmakinetic resection of prostate for benign prostatic hyperplasia (2021 Edition)"],"prefix":"10.1016","volume":"9","author":[{"given":"Xian-Tao","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Hui","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong-Zu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-Gang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Quan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bang-Min","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Li","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Li","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gong-Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Xing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Zhao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-Heng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Xiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiu-Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Heng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Jun","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Hong","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Xin","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Jun","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben-Kang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fa","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Xiang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Huai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Hui","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Hai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fa-Xian","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Yang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian-Yuan","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Qun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Feng","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nian-Zeng","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-Lin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2877-4345","authenticated-orcid":false,"given":"Xing-Huan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Chinese Urological Doctor Association (CUDA)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Urological Association of Chinese Research Hospital Association (CRHA-UA)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Uro-Health Promotive Association of China International Exchange and Promotive Association for Medical and Health Care (CPAM-UHPA)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","published-online":{"date-parts":[[2022,4,1]]},"reference":[{"issue":"6","key":"371_CR1","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.eururo.2014.12.038","volume":"67","author":"C Gratzke","year":"2015","unstructured":"Gratzke C, Bachmann A, Descazeaud A, Drake MJ, Madersbacher S, Mamoulakis C, et al. EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol. 2015;67(6):1099\u2013109.","journal-title":"Eur Urol"},{"issue":"1","key":"371_CR2","first-page":"64","volume":"8","author":"C Zhu","year":"2021","unstructured":"Zhu C, Wang DQ, Zi H, Huang Q, Gu JM, Li LY, et al. Epidemiological trends of urinary tract infections, urolithiasis and benign prostatic hyperplasia in 203 countries and territories from 1990 to 2019. Mil Med Res. 2021;8(1):64.","journal-title":"Mil Med Res"},{"key":"371_CR3","unstructured":"Wang XH, Wang HP, Feng ZW, Luo YX, Chen HY, Liu MJ. Transurethral Bipolar Resection of the Prostate. Med J Wuhan Univ. 2002;23(3):258\u20139+87 (in Chinese)"},{"issue":"5","key":"371_CR4","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.eururo.2009.06.037","volume":"56","author":"C Mamoulakis","year":"2009","unstructured":"Mamoulakis C, Ubbink DT, de la Rosette JJMCH. Bipolar versus monopolar transurethral resection of the prostate: a systematic review and meta-analysis of randomized controlled trials. Eur Urol. 2009;56(5):798\u2013809.","journal-title":"Eur Urol."},{"issue":"20","key":"371_CR5","first-page":"1549","volume":"98","author":"XT Zeng","year":"2018","unstructured":"Zeng XT, Weng H. Transurethral bipolar plasmakinetic prostatectomy treatment for benign prostatic hyperplasia in Chinese: development of a national evidence-based clinical practice guideline (2018 standard version). Natl Med J Chin. 2018;98(20):1549\u201360.","journal-title":"Natl Med J Chin"},{"key":"371_CR6","first-page":"7","volume":"7","author":"LL Ma","year":"2020","unstructured":"Ma LL, Wang YY, Yang ZH, Huang D, Weng H, Zeng XT. Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better? Mil Med Res. 2020;7:7.","journal-title":"Mil Med Res"},{"key":"371_CR7","unstructured":"EAU guideline-Management of Non-neurogenic Male LUTS. 2020. https:\/\/uroweb.org\/guideline\/treatment-of-non-neurogenic-male-luts\/."},{"issue":"7652","key":"371_CR8","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1136\/bmj.39493.646875.AE","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Kunz R, Falck-Ytter Y, Vist GE, Liberati A, et al. Going from evidence to recommendations. BMJ. 2008;336(7652):1049\u201351.","journal-title":"BMJ"},{"issue":"2","key":"371_CR9","doi-asserted-by":"publisher","first-page":"128","DOI":"10.7326\/M16-1565","volume":"166","author":"Y Chen","year":"2017","unstructured":"Chen Y, Yang K, Maru\u0161ic A, Qaseem A, Meerpohl JJ, Flottorp S, et al. A reporting tool for practice guidelines in health care: the right statement. Ann Intern Med. 2017;166(2):128\u201332.","journal-title":"Ann Intern Med"},{"issue":"4","key":"371_CR10","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1097\/JU.0000000000002184","volume":"206","author":"LB Lerner","year":"2021","unstructured":"Lerner LB, McVary KT, Barry MJ, Bixler BR, Dahm P, Das AK, et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline part II, surgical evaluation and treatment. J Urol. 2021;206(4):818\u201326.","journal-title":"J Urol"},{"issue":"10","key":"371_CR11","doi-asserted-by":"publisher","first-page":"303","DOI":"10.5489\/cuaj.5616","volume":"12","author":"JC Nickel","year":"2018","unstructured":"Nickel JC, Aaron L, Barkin J, Elterman D, Nachabe M, Zorn KC. AUA guideline: Canadian Urological Association guideline on male lower urinary tract symptoms\/benign prostatic hyperplasia (MLUTS\/BPH): 2018 update. Can Urol Assoc J. 2018;12(10):303\u201312.","journal-title":"Can Urol Assoc J"},{"key":"371_CR12","volume-title":"Guidelines for diagnosis and treatment of urological and andrological diseases in China","author":"YQ Na","year":"2014","unstructured":"Na YQ, Ye ZQ, Sun YH, Sun G. Guidelines for diagnosis and treatment of urological and andrological diseases in China. Beijing: People\u2019s Medical Publishing House Co., LTD; 2014."},{"key":"371_CR13","unstructured":"Urinary Health Promotion Branch of China Medical and Healthcare International Exchange Promotion Association, Urology Professional Committee of Chinese Research Hospital Association, National Key R&D Program Minimally Invasive Plasma Surgery System and Cloud Planning Solution Project Team. Chinese experts\u2019 consensus on the safety of transurethral plasmakinetic prostatectomy. J Mod Urol. 2018;23(12):890\u20134 (in Chinese)."},{"key":"371_CR14","volume-title":"Prostate surgery","author":"J Jin","year":"2013","unstructured":"Jin J. Prostate surgery. Beijing: People\u2019s Medical Publishing House Co., LTD; 2013."},{"issue":"4","key":"371_CR15","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1097\/01.ju.0000149676.15561.cb","volume":"173","author":"W Qiang","year":"2005","unstructured":"Qiang W, Jianchen W, Macdonald R, Monga M, Wilt TJ. Antibiotic prophylaxis for transurethral prostatic resection in men with preoperative urine containing less than 100,000 bacteria per ml: a systematic review. J Urol. 2005;173(4):1175\u201381.","journal-title":"J Urol"},{"issue":"4","key":"371_CR16","first-page":"262","volume":"22","author":"H Weng","year":"2017","unstructured":"Weng H, Wu KJ, Li T, Li XD, Zeng XT, Wang XH, et al. Efficacy and safety of Fosfomycin trometamol for urinary tract infection: a Meta-analysis. J Mod Urol. 2017;22(4):262\u201370 (in Chinese).","journal-title":"J Mod Urol"},{"key":"371_CR17","unstructured":"The General Office of the National Health and Family Planning Commission, the Office of the State Administration of Traditional Chinese Medicine and the Pharmaceutical Equipment Bureau of the Ministry of Health of the General Logistics Department of the People\u2019s Liberation Army. Guiding Principles for the Clinical Application of Antimicrobial Drugs (2015 Edition) (Annex [2015] No. 43 of the National Health Office) 2015. http:\/\/www.gov.cn\/xinwen\/2015-08\/27\/content_2920799.htm."},{"key":"371_CR18","volume-title":"Campbell\u2013Walsh urology 11th edition review","author":"WS McDougal","year":"2015","unstructured":"McDougal WS, Wein AJ, Kavoussi LR, Partin AW, Peters CA. Campbell\u2013Walsh urology 11th edition review. Amsterdam: Elsevier; 2015."},{"issue":"2","key":"371_CR19","first-page":"115","volume":"31","author":"YB Wang","year":"2021","unstructured":"Wang YB, Yan SY, Huang X, Guo XP, Deng YQ, Lou JX, et al. Efficacy and safety of transurethral plasmakinetic resection of prostate versus trans urethral resection for benign prostatic hyperplasia: a systematic review and meta-analysis. Yixue Xinzhi Zazhi. 2021;31(2):115\u201331 (in Chinese).","journal-title":"Yixue Xinzhi Zazhi"},{"key":"371_CR20","first-page":"15919","volume":"367","author":"SW Huang","year":"2019","unstructured":"Huang SW, Tsai CY, Tseng CS, Shih MC, Yeh YC, Chien KL, et al. Comparative efficacy and safety of new surgical treatments for benign prostatic hyperplasia: systematic review and network meta-analysis. BMJ. 2019;367:15919.","journal-title":"BMJ."},{"issue":"2","key":"371_CR21","first-page":"100","volume":"31","author":"XH Li","year":"2021","unstructured":"Li XH, Zi H, Huang X, Wang YB, Yan SY, Lou JA, et al. Efficy and safety of transurethral plasmakinetic resection of prostate versus transurethral plasmakinetic enucleation of prostate in treating benign prostate hyperplasia: a systematic review and meta-analysis. Yixue Xinzhi Zazhi. 2021;31(2):100\u201314 (in Chinese).","journal-title":"Yixue Xinzhi Zazhi"},{"issue":"21","key":"371_CR22","first-page":"4638","volume":"32","author":"Y Ji","year":"2012","unstructured":"Ji Y, Hu XS, Gy G. Comparison of the efficacy of transurethral plasmakinetic resection of the prostate and suprapubic transcystic prostatectomy in the treatment of benign prostatic hyperplasia. Chin J Gerontol. 2012;32(21):4638\u201340 (in Chinese).","journal-title":"Chin J Gerontol"},{"issue":"10","key":"371_CR23","first-page":"778","volume":"99","author":"ZY Zhang","year":"2019","unstructured":"Zhang ZY, Zhao MJ, Ba H, Ma LL, Yh J, Zeng XT, et al. A systematic review and meta-analysis of the effects of transurethral bipolar plasmakinetic prostatectomy in the treatment of high-risk elderly benign prostatic hyperplasia in China. Natl Med J Chin. 2019;99(10):778\u201382 (in Chinese).","journal-title":"Natl Med J Chin."},{"issue":"3","key":"371_CR24","doi-asserted-by":"publisher","first-page":"286","DOI":"10.23736\/S0393-2249.19.03282-X","volume":"71","author":"P Rai","year":"2019","unstructured":"Rai P, Srivastava A, Singh S, Dhayal IR. Comparison of bipolar plasmakinetic transurethral enucleation and resection of prostate gland in patients receiving anticoagulants and\/or platelet aggregation inhibitors. Minerva Urol Nefrol. 2019;71(3):286\u201393.","journal-title":"Minerva Urol Nefrol"},{"issue":"2","key":"371_CR25","first-page":"88","volume":"31","author":"BH Li","year":"2021","unstructured":"Li BH, Tang SD, Wang YB, Yan SY, Lou JA, Deng YQ, et al. Complications of transurethral plasmakinetic resection of prostate: a systematic review and meta-analysis. Yixue Xinzhi Zazhi. 2021;31(2):88\u201399 (in Chinese).","journal-title":"Yixue Xinzhi Zazhi"},{"issue":"5","key":"371_CR26","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.urology.2010.08.013","volume":"77","author":"X Huang","year":"2011","unstructured":"Huang X, Shi HB, Wang XH, Zhang XJ, Chen B, Men XW, et al. Bacteriuria after bipolar transurethral resection of the prostate: risk factors and correlation with leukocyturia. Urology. 2011;77(5):1183\u20137.","journal-title":"Urology"},{"key":"371_CR27","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.3389\/fphar.2019.01426","volume":"10","author":"BH Li","year":"2019","unstructured":"Li BH, Yu ZJ, Wang CY, Zi H, Li XD, Wang XH, et al. A preliminary, multicenter, prospective and real world study on the hemostasis, coagulation, and safety of hemocoagulase bothrops atrox in patients undergoing transurethral bipolar plasmakinetic prostatectomy. Front Pharmacol. 2019;10:1426.","journal-title":"Front Pharmacol"},{"issue":"12","key":"371_CR28","first-page":"39","volume":"34","author":"J Cao","year":"2017","unstructured":"Cao J, Ding Y, Huang YL, Zhang KX, Wang D, Lv C, et al. Effect of warming bladder rinse solution on bladder spasm after TURP surgeries: a meta-analysis. Nurs J Chin PLA. 2017;34(12):39\u201342 (in Chinese).","journal-title":"Nurs J Chin PLA"},{"issue":"6","key":"371_CR29","first-page":"18","volume":"24","author":"ZF Xiong","year":"2018","unstructured":"Xiong ZF, Tang LP. Application effect of bladder irrigation fluid heating method in postoperative bladder irrigation patients. Contemp Med. 2018;24(6):18\u201320 (in Chinese).","journal-title":"Contemp Med"},{"key":"371_CR30","volume-title":"Urinary incontinence","author":"FC Burkhard","year":"2020","unstructured":"Burkhard FC, Bosch JLHR, Cruz F, Lemack GE, Nambiar AK, Thiruchelvam NA. Urinary incontinence. Arnhem: EAU Guidelines Office; 2020."},{"issue":"2","key":"371_CR31","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/ijir.2009.56","volume":"22","author":"M Jaidane","year":"2010","unstructured":"Jaidane M, Arfa NB, Hmida W, Hidoussi A, Slama A, Sorba NB, et al. Effect of transurethral resection of the prostate on erectile function: a prospective comparative study. Int J Impot Res. 2010;22(2):146\u201351.","journal-title":"Int J Impot Res"},{"issue":"1","key":"371_CR32","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1745-7262.2006.00088.x","volume":"8","author":"V Poulakis","year":"2006","unstructured":"Poulakis V, Ferakis N, Witzsch U, De Vries R, Becht E. Erectile dysfunction after transurethral prostatectomy for lower urinary tract symptoms: results from a center with over 500 patients. Asian J Androl. 2006;8(1):69\u201374.","journal-title":"Asian J Androl"},{"key":"371_CR33","volume-title":"Male sexual dysfunction","author":"K Hatzimouratidis","year":"2019","unstructured":"Hatzimouratidis K, Giuliano F, Moncada I, Munner A, Salonia A, Verze P. Male sexual dysfunction. Arnhem: EAU Guidelines Office; 2019."},{"key":"371_CR34","volume-title":"Guideline for the diagnosis and treatment of erectile dysfunction in China (2016 version)","author":"CH Deng","year":"2017","unstructured":"Deng CH, Jiang H, Shang XJ, Andrology Branch of Chinese Medical Association. Guideline for the diagnosis and treatment of erectile dysfunction in China (2016 version). Beijing: People\u2019s Medical Publishing House Co., LTD; 2017."},{"issue":"1","key":"371_CR35","first-page":"57","volume":"32","author":"H Jiang","year":"2018","unstructured":"Jiang H, Deng CH, Shang XJ, Zhang ZC, Dai YT, Chen B, et al. Chinese expert consensus: Tadalafil 5mg once a day for the treatment of erectile dysfunction. Chin J Androl. 2018;32(1):57\u201362 (in Chinese).","journal-title":"Chin J Androl"},{"issue":"1","key":"371_CR36","first-page":"96","volume":"14","author":"J Liao","year":"2019","unstructured":"Liao J, Zhang X, Chen M, Li D, Tan X, Gu J, et al. Transurethral resection of the prostate with preservation of the bladder neck decreases postoperative retrograde ejaculation. Wideochir Inne Tech Maloinwazyjne. 2019;14(1):96\u2013101.","journal-title":"Wideochir Inne Tech Maloinwazyjne"},{"issue":"4","key":"371_CR37","doi-asserted-by":"publisher","first-page":"592","DOI":"10.21037\/tau.2016.06.05","volume":"5","author":"A Parnham","year":"2016","unstructured":"Parnham A, Serefoglu EC. Retrograde ejaculation, painful ejaculation and hematospermia. Transl Androl Urol. 2016;5(4):592\u2013601.","journal-title":"Transl Androl Urol"},{"issue":"5","key":"371_CR38","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.eururo.2004.07.020","volume":"46","author":"G Colpi","year":"2004","unstructured":"Colpi G, Weidner W, Jungwirth A, Pomerol J, Papp G, Hargreave T, et al. EAU guidelines on ejaculatory dysfunction. Eur Urol. 2004;46(5):555\u20138.","journal-title":"Eur Urol"},{"issue":"7\u20138","key":"371_CR39","doi-asserted-by":"publisher","first-page":"229","DOI":"10.5489\/cuaj.3209","volume":"9","author":"K Jarvi","year":"2015","unstructured":"Jarvi K, Lo K, Grober E, Mak V, Fischer A, Grantmyre J, et al. The workup and management of azoospermic males. Can Urol Assoc J. 2015;9(7\u20138):229\u201335.","journal-title":"Can Urol Assoc J"},{"issue":"1","key":"371_CR40","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1159\/000343235","volume":"90","author":"W Xiong","year":"2013","unstructured":"Xiong W, Sun M, Ran Q, Chen F, Du Y, Dou K. Learning curve for bipolar transurethral enucleation and resection of the prostate in saline for symptomatic benign prostatic hyperplasia: experience in the first 100 consecutive patients. Urol Int. 2013;90(1):68\u201374.","journal-title":"Urol Int"},{"issue":"2","key":"371_CR41","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1590\/s1677-5538.ibju.2016.0237","volume":"43","author":"L Feng","year":"2017","unstructured":"Feng L, Song J, Zhang D, Tian Y. Evaluation of the learning curve for transurethral plasmakinetic enucleation and resection of prostate using a mentor-based approach. Int Braz J Urol. 2017;43(2):245\u201355.","journal-title":"Int Braz J Urol"},{"issue":"7","key":"371_CR42","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1089\/end.2017.0092","volume":"31","author":"Y Hirasawa","year":"2017","unstructured":"Hirasawa Y, Kato Y, Fujita K. Transurethral enucleation with bipolar for benign prostatic hyperplasia: 2-year outcomes and the learning curve of a single surgeon\u2019s experience of 603 consecutive patients. J Endourol. 2017;31(7):679\u201385.","journal-title":"J Endourol"},{"issue":"1","key":"371_CR43","first-page":"70","volume":"49","author":"W Cao","year":"2015","unstructured":"Cao W, Zhang CY, Zhou L. Learning curve for transurethral plasmakinetic resection of prostate on benign prostate hyperplasia. J Harbin Med Univ. 2015;49(1):70\u20133 (in Chinese).","journal-title":"J Harbin Med Univ"},{"issue":"4","key":"371_CR44","first-page":"379","volume":"18","author":"Q Wang","year":"2018","unstructured":"Wang Q, Huang C, Li J, Jiang TD, Lu P, Zhao MJ, et al. Investigation and analysis of conflicts of interest and economic evidence in the clinical practice guidelines issued by China in 2017. Chin J Evid Based Med. 2018;18(4):379\u201387 (in Chinese).","journal-title":"Chin J Evid Based Med"},{"issue":"2","key":"371_CR45","first-page":"129","volume":"36","author":"YL Gui","year":"2017","unstructured":"Gui YL, Han S, Zeng XT, Wu B. The methodological quality assessment checklist of economic evaluation: an introduction. J Henan Univ (Med Sci). 2017;36(2):129\u201332 (in Chinese).","journal-title":"J Henan Univ (Med Sci)"},{"issue":"1","key":"371_CR46","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/jebm.12290","volume":"11","author":"XT Zeng","year":"2018","unstructured":"Zeng XT, Liu TZ, Gong K, He DL, Wang XH. The BPSC: a prospective study investigating the clinical effect of interventional therapy and the risk factors for bladder cancer and benign prostatic hyperplasia in Chinese population. J Evid Based Med. 2018;11(1):64\u20137.","journal-title":"J Evid Based Med"}],"container-title":["Military Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40779-022-00371-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40779-022-00371-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40779-022-00371-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T20:52:40Z","timestamp":1772830360000},"score":1,"resource":{"primary":{"URL":"https:\/\/mmrjournal.biomedcentral.com\/articles\/10.1186\/s40779-022-00371-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,1]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["371"],"URL":"https:\/\/doi.org\/10.1186\/s40779-022-00371-6","relation":{},"ISSN":["2054-9369"],"issn-type":[{"value":"2054-9369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,1]]},"assertion":[{"value":"13 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No one reported having stock, being a consultant paid by companies or receiving research funding from companies that have an interest in the guideline. Yin-Huai Wang reported publishing the paper comparing TUPKP and TURP in the treatment of BPH, the paper related to the perioperative management of TUPKP for the treatment of BPH and the paper related to complications of TUPKP for the treatment of BPH. Zhong Wang reported publishing the paper comparing TUPKP and TURP in the treatment of BPH, the paper comparing TUPKP and TUPEP in the treatment of BPH, and applied for the patent related to TUPKP and the patent related to TUPEP for the treatment of BPH. Min-Hui Xiao reported publishing the paper related to complications of TUPKP for the treatment of BPH. Zhi-Ping Wang reported publishing the paper comparing TUPKP and TURP in the treatment of BPH, the paper comparing TUPKP and TUPEP in the treatment of BPH, the paper comparing TUPKP and OP in the treatment of BPH, the paper related to the perioperative management of TUPKP for the treatment of BPH, the paper related to complications of TUPKP for the treatment of BPH, and has applied for the patent related to TUPKP, the patent related to TURP for the treatment of BPH, and the patent related to the perioperative management of TUPKP for the treatment of BPH. Zhi-Ping Wang also reported publishing the paper on prevention of complications of transurethral surgery for BPH and water intoxication. No other disclosures were reported.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14"}}